Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

Aldehyde-mediated inhibition of asparagine biosynthesis has implications for diabetes and alcoholism

Evidence

Chem Sci. 2024 Jan 15;15(7):2509-2517. doi: 10.1039/d3sc06551k. eCollection 2024 Feb 14.

ABSTRACT

Patients with alcoholism and type 2 diabetes manifest altered metabolism, including elevated aldehyde levels and unusually low asparagine levels. We show that asparagine synthetase B (ASNS), the only human asparagine-forming enzyme, is inhibited by disease-relevant reactive aldehydes, including formaldehyde and acetaldehyde. Cellular studies show non-cytotoxic amounts of reactive aldehydes induce a decrease in asparagine levels. Biochemical analyses reveal inhibition results from reaction of the aldehydes with the catalytically important N-terminal cysteine of ASNS. The combined cellular and biochemical results suggest a possible mechanism underlying the low asparagine levels in alcoholism and diabetes. The results will stimulate research on the biological consequences of the reactions of aldehydes with nucleophilic residues.

PMID:38362406 | PMC:PMC10866355 | DOI:10.1039/d3sc06551k

Document this CPD Copy URL Button

Google

Google Keep Add to Google Keep

LinkedIn Share Share on Linkedin Share on Linkedin

Estimated reading time: 3 minute(s)

Latest: Psychiatryai.com #RAISR4D

Real-Time Evidence Search [Psychiatry]

Aldehyde-mediated inhibition of asparagine biosynthesis has implications for diabetes and alcoholism

🌐 90 Days

Evidence Blueprint

Aldehyde-mediated inhibition of asparagine biosynthesis has implications for diabetes and alcoholism

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

Save Evidence Blueprint

Save as PDF

Aldehyde-mediated inhibition of asparagine biosynthesis has implications for diabetes and alcoholism

🌐 365 Days

close chatgpt icon
ChatGPT

Enter your request.